Cedric Franklin Rutland
Critical Care Medicine · Newport Beach, CA
CMS Profile ID: 984568 · NPI: 1811122799
Total Disclosed General Payments
$731,447.34
General-payment records
464
CMS Program Year
2025
Most of this (about 62%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $451,284.48 |
| Consulting Fee | $121,390.04 |
| Grant | $70,000.00 |
| Travel and Lodging | $69,971.65 |
| Food and Beverage | $12,783.96 |
| Honoraria | $6,000.00 |
| Gift | $17.21 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| GENZYME CORPORATION | $211,727.95 |
| AstraZeneca Pharmaceuticals LP | $183,892.24 |
| GlaxoSmithKline, LLC. | $181,296.93 |
| Regeneron Healthcare Solutions, Inc. | $101,010.46 |
| Medtronic, Inc. | $26,612.75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,191.51 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1811122799 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1811122799.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.